Stem cells for advanced hepatitis B cirrhosis safety
Treatments studied
Part of Digestive system, Infections clinical trials.
This trial studies whether umbilical cord stem cells are safe for people with advanced (decompensated) hepatitis B cirrhosis. It mainly looks at safety and whether symptoms or quality of life improve after standard care has not helped enough.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re between 18 and 75 years old (either sex).
- You have decompensated hepatitis B cirrhosis diagnosed by accepted guidelines.
- After more than 3 months of strict standard treatments, you have not improved much in symptoms or quality of life.
- Your HBV DNA level is 1000 IU/mL or lower at screening.
- You can understand the consent form and agree to take part voluntarily.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an injection of stem cells from donated umbilical cords to see if it can help people with advanced liver scarring from hepatitis B. You may be able to join if standard treatments haven’t helped enough and you aren’t able to get a liver transplant.
This early-stage trial tests umbilical cord “mesenchymal” stem cells in people with liver scarring (cirrhosis) that is caused by hepatitis B. It may help improve liver function and related complications, but it is mainly designed to check safety and how well the treatment works.
This Phase 1 study tests a stem cell product to see if it is safe and how it affects people with worsening hepatitis B-related cirrhosis. It may help researchers understand whether the treatment could improve liver function in this stage of illness.
This trial tests whether a type of stem cell therapy is safe for people with liver cirrhosis caused by alcohol, hepatitis B, or hepatitis C. It may help if your liver disease is controlled and you have moderate to severe cirrhosis.
This trial tests if infusions of stem cells from donated umbilical cords can help people with a severe type of liver failure caused by hepatitis B. It aims to see if the treatment is safe and can improve liver function.
This trial tests umbilical-cord stem cells to see if they can improve outcomes in people with decompensated (worsening) cirrhosis. You may be considered if your liver disease is moderate to severe (MELD 15–30) and you do not have certain high-risk problems right now.
Hear when a new Decompensated Liver Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.